CAS: 21662-09-9; Cis-4-Decenal

相似化合物

26303-90-2 57074-37-0 76649-16-6

上下游产品

(Z)-4-decen-1-ol 1,1-dimethoxy-4Z-decene 1,1-dimethoxy-8-tosyloxy-(4Z)-°Ctene (Z)-4-decenoic acid ethyl esterethyl trans-2, cis-6-dodecadienoate (Z)-dec-4-enoic acid (Z)-1-Phenyl-dec-4-en-1-ol (Z)-4-decen-1-ol

📜(Z)-4-癸烯酸乙酯置于lithium Aluminium Tetrahydride,Pyridinium Chlorochromate体系中,用 乙醚,二氯甲烷 用作溶剂,化学反应 2.0H,反应生成(Z)-4-癸烯醛
参考文献:信息素xxxii.代表双不饱和蝴蝶信息素的构建基块
标题:信息素xxxii.代表双不饱和蝴蝶信息素的构建基块
摘要:描述了通过wittig反应,Michael加成,乙炔合成或crombie反应获得的α,ω-双功能起始化合物以及(z)和(e)构型的不饱和合成结构单元的表示.这些化合物是合成双烯烃性信息素的"模块系统"的一部分.
Doi:10.1002/jlac.198119810920

专利信息

专利号:US-4895996-A
优先权日:1988-10-17
标 题 :Synthesis of alkenes from enamines via hydroboration
发明人：GORALSKI CHRISTIAN T; SINGARAM BAKTHAN; BROWN HERBERT C
权利人:PURDUE RESEARCH FOUNDATION; DOW CHEMICAL CO
摘要:Alkenes are prepared by the hydroboration of enamines followed by an elimination reaction to form the alkene. This process has wide applicability and is useful for the stereospecific synthesis of [Z] isomers. It is preferred to use 9-borabicyclo[3.3.1 nonane as the hydroborating agent and to use methanol to catalyze the elimination reaction.

专利号:US-2005004225-A1
优先权日:2003-04-16
标题:Oxidoreductase inhibitors and methods of screening and using thereof
发明人：BALENDIRAN GANESARATNAM K
摘要:The present invention relates to 1) the design and synthesis of analogs to glutathione conjugates which bind to or interact with aldose reductase (AR) through unique conformations that are distinctly different from the substrates and inhibitors of AR which are members of sugar metabolism; 2) the screening of the analogs to identify those that interact with or inhibit or enhance the activity of AR; and 3) the use of AR ligands, AR inhibitors (AR antagonsits) or AR enhancer (AR agonists) in the detection of AR activity, the modulation of AR activity, and the treatment of conditions in a subject in need of modulating AR activity. Such conditions include but not limited to cardiovascular disease, diabetes, artheriosclerosis, cancer, neoplasm, obesity, cataract, retinopathy, keratopathy, nephropathy, neurosis, thrombosis, faulty union of corneal injury and neuropathy. Examples of the treatment include the use of fibrates as AR inhibitors to treat these conditions.

专利号:WO-0053313-A2
优先权日:1999-03-09
标 题:Lanthanide catalysts for synthesis of compounds and combinatorial libraries

专利号:US-10647942-B2
优先权日:2016-12-22
标题:Fragrance and flavor materials
发明人：BLANDINO MAUREEN; LANKIN MICHAEL E
权利人:TAKASAGO PERFUMERY CO LTD
摘要:The present disclosure is directed to the synthesis and application of undecavertol derivatives having unique and desired flavor and/or fragrant characteristics. The compounds of the present disclosure can be employed alone or incorporated as fragrance or flavor ingredients in fragrance or flavor compositions. The present disclosure is also directed to consumer products comprising such derivatives and/or fragrance or flavor compositions.

专利号:US-2025091984-A1
优先权日:2022-04-07
标题:Fragrance and flavor materials
发明人：DICKERSON THALIA S; TURESKI ROBERT; BLANDINO MAUREEN
权利人:TAKASAGO PERFUMERY CO LTD
摘要:The present disclosure is directed to the synthesis and application of novel compounds having unique and desired flavor and/or fragrance characteristics. The compounds of the present disclosure can be employed alone or incorporated as fragrance or flavor compounds in fragrance or flavor compositions. The present disclosure is also directed to consumer products comprising such fragrance or flavor compounds and/or fragrance or flavor compositions.

专利号:US-12114681-B2
优先权日:2018-06-04
标题:Fragrance and flavor materials
发明人：BLANDINO MAUREEN; TANUMA KENJI
权利人:TAKASAGO PERFUMERY CO LTD
摘要:The synthesis and application of compounds having unique and desired flavor and/or fragrance characteristics are provided herein. The compounds herein can be employed alone or incorporated as fragrance or flavor ingredients in fragrance or flavor compositions. The application is also directed to consumer products comprising such derivatives and/or fragrance or flavor compositions.